Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

Benzinga · 1d ago
Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.